Zug, Zug, Switzerland
Extensive international pharmaceutical leadership experience with demonstrated track record of growing sales and enhancing profitability in generics, branded pharmaceuticals and OTCs In depth knowledge of customers (GPs, specialists, hospitals, pharmacies, drugstores, and wholesalers) and their operations (prescribing, tendering, dispensing, and distributing) Excellent general management skills at the regional level and leadership ability to achieve accountable execution at the country level Strong focus on financial management throughout the business, maximizing cash flow, EBITDA, ROCE, incl. focus on sales and operational planning Excellent Key Account Management results with wholesalers, retail chains and Government agencies. Strong business development capabilities through product launches, cross pollination of BD initiatives between the subsidiaries and alliance partnerships, and exploitation of market and brand/product opportunities Creating value through organizational development; re-design/restructuring, people development/competence building, cultural realignment, process optimization Proven record accomplishing M&A integration and maximizing synergies
Doubled turnover and adjusted EBITDA Completed 3 portfolio acquisitions Upscaled and upgraded the operational platform to meet requirements of a global pharma organization
Established and managed the global commercial and distribution organisation (ex. USA) Transferred, integrated and grew portfolio of asthma and COPD treatments acquired from AstraZeneca
Launch of Ozain (paediatric anaesthesiology) in Europe